How have we been lending a hand to the COVID-19 effort?
June 9, 2020

COVID-19 is undoubtedly having an impact on patient populations. During this challenging time, Talking Medicines have been doing their bit to support the Medsmart® community whilst sharing data insight from greater patient populations to add value to Government data, to help others and raise awareness of the work we are doing.

COVID-19 Tracker

The UK statistics show that there are 15,639 confirmed cases of COVID-19 in Scotland and 155,000, 14,438 and 4,802 in England, Wales and Northern Ireland respectively (The Guardian). To play our part in tracking and to support our Medsmart® community we created a new version of our App – inclusive of a COVID-19 tracker. So far we have had an uptake of 2.82% across our Medsmart® community with a proportion of users confirming that they have tested positive for COVID-19, another group that think they may have COVID-19 and a further subset of users that are using this feature to state that they are unaffected. We are delighted to that there is use of the tracker already and intend to keep this feature in the App over the coming months to support users and add value to coronavirus data as time goes on. The profile of those experiencing symptoms are expressed in the infographic below:

Tracking impact of the pandemic on medicines uploaded to Medsmart®

We have also been looking at the medicines being scanned into our Medsmart® App over the last few months. We can see that over the course of the pandemic the top five medicines uploaded were: Omeprazole, levothyroxine, sertraline, atorvastatin and Ramipril. These drugs are used to treat gastric acid, hypothyroidism, depression, high cholesterol and high blood pressure respectively.

We believe that the data we collect about how people talk about their health and use their medicines can be used for good. It is important to us that we use our tools not only to connect patients with the wider healthcare system but also to connect the healthcare system back to the patients and their voices. We hope that by continuing to collate and structure data from our COVID-19 Tracker and by analysing changes in user medicine uploads we can continue to contribute to the COVID-19 effort as it enters this new “test and trace” phase.

 

Ref: https://www.theguardian.com/world/2020/jun/09/coronavirus-uk-map-the-latest-deaths-and-confirmed-cases-near-you

Recent Blogs

Softening of public attitude towards COVID-19 vaccines

Softening of public attitude towards COVID-19 vaccines

In December Talking Medicines carried out two ‘pulse’ surveys of the UK public to gauge opinion towards COVID-19 vaccines and found that over the month, attitude had softened, with more people intending to take the vaccine once it becomes available to them. The...

Growing the Product Tech Team

Growing the Product Tech Team

We are so pleased to welcome four talented individuals to our team. Through their knowledge and experience, we look forward to accelerating our AI driven data insights product aligned to the needs of our commercial marketing pharmaceutical customers. Stewart McKee -...

AstraZeneca and Oxford University gain approval on new COVID-19 vaccine

AstraZeneca and Oxford University gain approval on new COVID-19 vaccine

The UK has now approved its second vaccine for COVID-19. Last week, AstraZeneca (Pharmaceutical company) and Oxford University’s vaccine was approved for use and has since been administered to the public. From this week there will be half a million doses available for...